69
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry

, , , , , , & show all
Pages 971-979 | Published online: 04 Jul 2014

References

  • Castro-BorreroWGravesDFrohmanTCCurrent and emerging therapies in multiple sclerosis: a systematic reviewTher Adv Neurol Disord20125420522022783370
  • RudickRAPolmanCHCurrent approaches to the identification and management of breakthrough disease in patients with multiple sclerosisLancet Neurol20098654555919446274
  • FoxRSalterAAlsterJRisk tolerance in MS patients: survey results from the NARCOMS registryNeurology2011769S4
  • GiovannoniGRhoadesRWIndividualizing treatment goals and interventions for people with MSCurr Opin Neurol201225SupplS20S2722398661
  • HeesenCKasperJSegalJKöpkeSMühlhauserIDecisional role preferences, risk knowledge and information interests in patients with multiple sclerosisMult Scler200410664365015584489
  • MarrieRACutterGTyryTCampagnoloDVollmerTValidation of the NARCOMS registry: diagnosisMult Scler200713677077517525097
  • JacobsLDWendeKEBrownscheidleCMA profile of multiple sclerosis: the New York State Multiple Sclerosis ConsortiumMult Scler19995536937610516782
  • WeinshenkerBGBassBRiceGPThe natural history of multiple sclerosis: a geographically based study. I. Clinical course and disabilityBrain1989112Pt 11331462917275
  • TaylorBVPalmerASimpsonSJrLucasRNZMSPS study groupSimmonsRDMasonDAssessing possible selection bias in a national voluntary MS longitudinal study in AustraliaMult Scler201319121627163123530001
  • HoholMJOravEJWeinerHLDisease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progressionMult Scler19995534935410516779
  • MarrieRAGoldmanMValidity of performance scales for disability assessment in multiple sclerosisMultiple sclerosis20071311768217623733
  • LearmonthYCMotlRWSandroffBMPulaJHCadavidDValidation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosisBMC Neurology2013133723617555
  • MarrieRACutterGTyryTVollmerTCampagnoloDDoes multiple sclerosis-associated disability differ between races?Neurology20066681235124016636241
  • CollinsJGPrevalence of selected chronic conditions: United States, 1986–1988Vital Health Stat 101993182187
  • HeesenCKasperJKöpkeSRichterTSegalJMühlhauserIInformed shared decision making in multiple sclerosis – inevitable or impossible?J Neurol Sci20072591–210911717400253
  • KasperJHeesenCKöpkeSFulcherGGeigerFPatients’ and observers’ perceptions of involvement differ. Validation study on inter-relating measures for shared decision makingPloS One2011610e2625522043310
  • CharlesCGafniAWhelanTShared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)Soc Sci Med19974456816929032835
  • AndersonRMFunnellMMPatient empowerment: reflections on the challenge of fostering the adoption of a new paradigmPatient Educ Couns200557215315715911187
  • RíoJTintoréMSastre-GarrigaJChange in the clinical activity of multiple sclerosis after treatment switch for suboptimal responseEur J Neurol201219689990422289050
  • Castillo-TrivinoTMowryEMGajofattoASwitching multiple sclerosis patients with breakthrough disease to second-line therapyPloS One201162e1666421304907
  • ProsperiniLGianniCLeonardiLEscalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosisMult Scler2012181647121828195